Medy-Tox Future Growth
Future criteria checks 4/6
Medy-Tox is forecast to grow earnings and revenue by 63.9% and 12.4% per annum respectively. EPS is expected to grow by 63.8% per annum. Return on equity is forecast to be 11.8% in 3 years.
Key information
63.9%
Earnings growth rate
63.8%
EPS growth rate
Biotechs earnings growth | 63.6% |
Revenue growth rate | 12.4% |
Future return on equity | 11.8% |
Analyst coverage | Good |
Last updated | 13 Aug 2024 |
Recent future growth updates
Recent updates
Medy-Tox Inc. (KOSDAQ:086900) Surges 37% Yet Its Low P/S Is No Reason For Excitement
Jul 19Medy-Tox's (KOSDAQ:086900) Anemic Earnings Might Be Worse Than You Think
Mar 31Medy-Tox Inc.'s (KOSDAQ:086900) Prospects Need A Boost To Lift Shares
Feb 27Tread With Caution Around Medy-Tox Inc.'s (KOSDAQ:086900) 0.4% Dividend Yield
Apr 02A Look At Medy-Tox's (KOSDAQ:086900) Share Price Returns
Feb 09Read This Before Buying Medy-Tox Inc. (KOSDAQ:086900) For Its Dividend
Dec 18Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 326,592 | 76,533 | 75,555 | 95,380 | 5 |
12/31/2025 | 297,452 | 59,603 | 47,948 | 70,646 | 6 |
12/31/2024 | 258,371 | 34,759 | 37,337 | 66,117 | 3 |
3/31/2024 | 233,035 | 1,751 | -9,935 | 25,086 | N/A |
12/31/2023 | 221,121 | 8,780 | -23,947 | 13,522 | N/A |
9/30/2023 | 205,386 | 10,346 | -10,459 | 21,773 | N/A |
6/30/2023 | 200,043 | 25,877 | -1,798 | 30,079 | N/A |
3/31/2023 | 198,012 | 36,545 | -13,797 | 13,915 | N/A |
12/31/2022 | 195,096 | 36,035 | 1,099 | 26,199 | N/A |
9/30/2022 | 182,052 | 23,216 | 6,700 | 29,848 | N/A |
6/30/2022 | 198,617 | 30,632 | 7,983 | 32,684 | N/A |
3/31/2022 | 192,805 | 43,052 | 24,942 | 47,932 | N/A |
12/31/2021 | 184,870 | 93,179 | -1,378 | 19,966 | N/A |
9/30/2021 | 175,194 | 89,727 | -37,235 | -6,137 | N/A |
6/30/2021 | 141,110 | 69,059 | -20,333 | -1,541 | N/A |
3/31/2021 | 138,761 | 31,503 | -34,575 | -7,150 | N/A |
12/31/2020 | 140,828 | -29,577 | -16,379 | 27,927 | N/A |
9/30/2020 | 169,531 | -12,877 | 14,421 | 50,326 | N/A |
6/30/2020 | 182,101 | -9,739 | -1,676 | 43,616 | N/A |
3/31/2020 | 195,537 | 6,671 | -3,132 | 39,623 | N/A |
12/31/2019 | 205,900 | 26,206 | 10,039 | 33,703 | N/A |
9/30/2019 | 191,069 | 43,578 | 20,512 | 42,313 | N/A |
6/30/2019 | 190,954 | 54,898 | 21,904 | 39,389 | N/A |
3/31/2019 | 190,887 | 62,348 | 27,467 | 39,296 | N/A |
12/31/2018 | 205,445 | 69,964 | 43,049 | 55,071 | N/A |
9/30/2018 | 215,001 | 72,978 | 55,864 | 66,876 | N/A |
6/30/2018 | 207,067 | 71,844 | 45,960 | 70,852 | N/A |
3/31/2018 | 199,573 | 74,394 | 38,760 | 72,113 | N/A |
12/31/2017 | 181,239 | 70,106 | N/A | 56,546 | N/A |
9/30/2017 | 168,236 | 65,816 | N/A | 44,835 | N/A |
6/30/2017 | 160,927 | 67,142 | N/A | 48,247 | N/A |
3/31/2017 | 144,971 | 62,573 | N/A | 55,349 | N/A |
12/31/2016 | 133,256 | 59,231 | N/A | 54,101 | N/A |
9/30/2016 | 118,090 | 55,656 | N/A | 48,000 | N/A |
6/30/2016 | 108,114 | 51,536 | N/A | 37,272 | N/A |
3/31/2016 | 98,465 | 47,367 | N/A | 35,453 | N/A |
12/31/2015 | 88,505 | 42,293 | N/A | 22,356 | N/A |
9/30/2015 | 78,066 | 37,393 | N/A | 21,963 | N/A |
6/30/2015 | 87,180 | 48,726 | N/A | 37,679 | N/A |
3/31/2015 | 81,388 | 45,602 | N/A | 34,354 | N/A |
12/31/2014 | 75,892 | 43,628 | N/A | 105,379 | N/A |
9/30/2014 | 70,699 | 41,200 | N/A | 103,756 | N/A |
6/30/2014 | 48,631 | 22,938 | N/A | 85,950 | N/A |
3/31/2014 | 43,640 | 18,419 | N/A | 84,684 | N/A |
12/31/2013 | 39,141 | 14,304 | N/A | 16,596 | N/A |
9/30/2013 | 40,719 | 13,762 | N/A | 12,621 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: A086900's forecast earnings growth (63.9% per year) is above the savings rate (2.6%).
Earnings vs Market: A086900's earnings (63.9% per year) are forecast to grow faster than the KR market (28.5% per year).
High Growth Earnings: A086900's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: A086900's revenue (12.4% per year) is forecast to grow faster than the KR market (10.4% per year).
High Growth Revenue: A086900's revenue (12.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: A086900's Return on Equity is forecast to be low in 3 years time (11.8%).